Posted: December 13th, 2018
Judgments in Cases T-677/14 Biogaran v. Commission, T-679/14 Teva UK and Others v. Commission, T680/14 Lupin v. Commission, T-682/14 Mylan Laboratories and Mylan v. Commission, T-684/14 Krka v. Commission, T-701/14 Niche Generics v. Commission, T-705/14 Unichem Laboratories v. Commission, T-691/14 Servier and Others v. Commission, General Court of the European Union, Luxembourg, 12 December 2018
PRESS RELEASE No 194/18:
The General Court annuls in part the European Commission’s decision finding the existence of restrictive agreements and an abuse of a dominant position on the market for perindopril, a medicine used to treat hypertension and heart failure.
The General Court confirms, however, that certain patent settlement agreements may be restrictive of competition by object
The full press release can be read here.